Henry Schein Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Henry Schein Inc in the second quarter 2026?
Henry Schein Inc achieved a return on average equity (ROE) of 10.88 % in its second quarter 2026, which is below Henry Schein Inc 's average return on equity, which stands at 15.18%.

While the company's net income was fading, Henry Schein Inc was able to improve its ROE compared to the first quarter 2026.

Within the Medical Equipment & Supplies industry 34 other companies had a higher return on equity. While Return on equity, overall ranking has advanced in the quarter, so far to 1377, from total ROE ranking in the first quarter 2026 at 1553.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Jun 27 2026) II. Quarter	(Mar 28 2026) I. Quarter	(Dec 27 2025) IV. Quarter	(Sep 27 2025) III. Quarter	(Jun 28 2025) II. Quarter
Y / Y Equity Change	-6.63 %	-0.89 %	-3.27 %	-2.8 %	-
Y / Y Net Income Change	8.51 %	-0.88 %	7.29 %	10.1 %	-10.48 %
Net Income (TTM) in Millions	426	418	419	412	402
Return On Equity (TTM)	10.88 %	10.5 %	10.5 %	10.24 %	9.92 %
HSIC's Total Ranking	# 1377	# 1553	# 1348	# 1384	# 1331
Equity (TTM) in Millions	3,817	3,919	3,899	4,023	4,088
Seq. Equity Change	-2.6 %	0.51 %	-3.08 %	-1.59 %	3.39 %
Seq. Net Income Change	-8.93 %	8.74 %	-5.5 %	15.96 %	-16.81 %

Back to HSIC Management Effectiveness >> HSIC's 5 Years Annual ROE >> Compare HSIC ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 35
Sector	# 133
Overall	# 1377

Return On Equity Statistics
High	Average	Low
20.94 %	15.18 %	7.59 %
(Jul 01 2017)		(Sep 28 2024)

HSIC Annual Return On Equity	(Dec 27 2025) 2025	(Dec 28 2024) 2024	(Dec 30 2023) 2023	(Dec 31 2022) 2022	(Dec 25 2021) 2021
Total Equity in Millions	3,899	4,031	4,289	4,095	4,063
Y / Y Equity Change	-3.27 %	-6.02 %	4.74 %	0.78 %	1.98 %
Net Income in Millions	419	398	436	566	661
Y / Y Net Income Change	5.28 %	-8.72 %	-22.97 %	-14.31 %	57.48 %
Return On Equity	10.75 %	9.87 %	10.17 %	13.82 %	16.26 %

Back to HSIC Management Effectiveness >> HSIC's 5 Years Annual ROE >> Compare HSIC ROE to its Competitors

Annual Roe Comment

In 2025 ROE improved to 10.75 % compared to the previous year, due to net income growth.

More Return On Equity Ratios
Medical Equipment & Supplies Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
HSIC's' Return on Equity at Yahoo Finance
HSIC's Roe Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for HSIC's Competitors
Subscribers only: Roe for Henry Schein Inc 's Suppliers
Subscribers only: Return On Equity for HSIC's Customers

Companies with similar Return On Equity at Jun 27 2026, within Healthcare Sector	ROE
Phibro Animal Health Corporation	29.66 %
Chemed Corporation	29.45 %
Solventum Corporation	28.96 %
Pacs Group Inc	27.00 %
Sotera Health Company	26.75 %
Insulet Corporation	26.69 %
Bioventus Inc	25.96 %
Johnson and Johnson	25.74 %
Encompass Health Corporation	25.52 %
Resmed Inc	24.21 %
Healthcare Services Group Inc	24.12 %
Electromed Inc	23.65 %
Iradimed Corporation	23.45 %
Vertex Pharmaceuticals Inc	23.31 %
Lantheus Holdings Inc	23.27 %
Msa Safety Inc	23.15 %
Prestige Consumer Healthcare Inc	21.77 %
Jazz Pharmaceuticals Plc	21.37 %
Neurocrine Biosciences Inc	21.13 %
Universal Health Services Inc	20.89 %
Puma Biotechnology Inc	20.85 %
Entera Bio Ltd	20.82 %
United Therapeutics Corporation	20.18 %
Ligand Pharmaceuticals Incorporated	20.06 %
Harmony Biosciences Holdings inc	20.06 %
Pediatrix Medical Group Inc	19.89 %
Theravance Biopharma inc	19.40 %
Krystal Biotech Inc	19.34 %
Ani Pharmaceuticals Inc	19.33 %
Brightspring Health Services Inc	18.93 %

Date modified: 2026-09-26T07:16:13+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.